|
Cost of Illness Study of Type 2 Diabetes Mellitus in Indonesia
|
|
| Author:
|
YUNITA NITA, DIAS PUTRI WARDANASARI, DIVA ARIADNE CERELIA, FITRI NURMALASARI, TUTUT DWI CAHYATI, ABDUL RAHEM, LIZA PRISTIANTY, MUFARRIHAH
|
| Abstract:
|
Introduction: The economic burden of diabetes could result in public health problems. To formulate an effective response, it is important to understand the cost of illness of the disease. This study aimed to determine the cost of illness in type 2 diabetes mellitus patients in Surabaya, Indonesia.
Methods: The study was conducted in 15 Primary Healthcare Centers in Surabaya on January-March 2019. This was a cross sectional study using purposive sampling method. The study was based on a societal perspective. The cost measurement method used a list of interview questions to determine the cost of illness.
Results: Fifteen Primary Health Care Centers in Surabaya were chosen. A number of 218 patients who received either insulin (in monotherapy or combination) or oral antidiabetic drug (in monotherapy or combination) were interviewed. Results showed that the average total annual costs of type 2 diabetes mellitus patients was IDR 1,712,133.30 ± 2,498,851.17 per patient per year; direct medical costs was IDR 1,274,307.43 ± 2,395,862.84 per patient per year; direct non-medical costs was IDR 145,812.62 ± 299,984.61 per patient per year; and indirect cost was IDR 292,013.24 ± 483,597.68 per patient per year. The highest cost was direct medical cost which was drug cost accounted for IDR 969,730.10 ± 2,343,852.46 per patient per year.
Conclusion: This study provides important data regarding cost of illness in type 2 diabetes mellitus patients and can be used as a guide for further research and policy.
|
| Keyword:
|
Cost of illness, type 2 diabetes mellitus, primary health care center
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.01.044
|
| Download:
|
Request For Article
|
|
|